+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

“Advanced Wound Care market set to grow to $13.8bn by 2024” says Visiongain report

03 October 2019
Pharma

Visiongain has published a new pharma report Top 20 Advanced Wound Care Companies 2020: Smith & Nephew Plc., ConvaTec Group Plc., Coloplast A/S, 3M, B. Braun Melsungen AG and Other Companies.

Wound care is essential in improving the quality of life and overall well-being. The wound care industry is highly competitive and diverse with immense potential for growth. Drivers for growth include an increasingly ageing population, rising prevalence of diabetes and obesity, and growing patient awareness.

The number of patients suffering from all forms of chronic wounds is increasing worldwide at around 8% per year; this increasing incidence provides an avenue for substantial growth in the advanced wound care market over the coming years.

This report profiled the selected companies: Smith & Nephew, Acelity L.P. Inc., Mölnlycke Health Care, ConvaTec Group plc, Coloplast A/S, 3M Company, B. Braun Melsungen AG, BSN Medical GmbH, Cardinal Health, Inc. and other companies.

The lead analyst commented that "Being the largest and fastest growing segment of the wound care market, the Advanced wound care market will witness healthy growth during the forecast period. Growth in this market is set to be driven by the increasing awareness of current technologies, launch of new innovative products and rapidly expanding emerging economies. During the course of the forecast period, more companies are expected to expand their operations into developing economies."

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

23 April 2024

Read

Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

18 April 2024

Read

Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

17 April 2024

Read

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

12 April 2024

Read